Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2021-12-03 Regulatory Filings
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(TG-C 추가 적응증 미국FDA 임상2상 검토(Review) 완료 )
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene regarding the completion of a US FDA review for a Phase 2 clinical trial protocol for TG-C (hip osteoarthritis). It is a formal disclosure of a material business event (major management matter) filed with a regulatory body. Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a direct regulatory disclosure of a clinical trial status update, it falls under the 'Regulatory Filings' category.
2021-12-03 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정), which involves the issuance of new shares to third parties (third-party allocation). This falls under the category of announcements regarding new share issues or capital changes.
2021-12-02 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Kolon TissueGene, Inc. covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, business operations, management analysis, and corporate governance disclosures, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself. 9M 2021
2021-11-15 Korean
기타시장안내(기업심사위원회 심의·의결 결과 및 개선기간 부여 안내)
Legal Proceedings Report Classification · 100% confidence The document is a formal announcement from the Korea Exchange regarding the 'Corporate Review Committee' decision on Kolon TissueGene, specifically concerning listing eligibility, improvement periods, and potential delisting procedures. This is a regulatory announcement regarding the company's listing status and does not fit into specific categories like financial reports or dividend notices. Therefore, it is classified as a Regulatory Filing (RNS).
2021-08-31 Korean
주권매매거래정지기간변경(개선기간 부여)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ market regarding a change in the trading suspension period for Kolon TissueGene. It cites specific market regulations and provides details on the suspension timeline. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or dividends, it falls under the general regulatory filing category.
2021-08-31 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Kolon TissueGene, Inc. covering the period from January 1, 2021, to June 30, 2021. It contains detailed sections on company overview, business operations, financial information, and management analysis, which are characteristic of an interim/quarterly report. It is not a mere announcement or certification, but the full report itself. H1 2021
2021-08-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.